Cargando…

Sickle Cell Anemia Patients in Use of Hydroxyurea: Association between Polymorphisms in Genes Encoding Metabolizing Drug Enzymes and Laboratory Parameters

This study investigated associations between SNPs in genes encoding metabolizing drug enzymes and laboratory parameters in sickle cell anemia patients under hydroxyurea (SCA-HU(+)). We evaluated hematologic and biochemical parameters by electronic methods and SNPs by PCR-RFLP and multiplex PCR in 35...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yahouédéhou, Sètondji Cocou Modeste Alexandre, Carvalho, Magda Oliveira Seixas, Oliveira, Rodrigo Mota, Santiago, Rayra Pereira, da Guarda, Caroline Conceição, Carvalho, Suellen Pinheiro, Ferreira, Júnia Raquel Dutra, Aleluia, Milena Magalhães, Adorno, Elisângela Vitória, Gonçalves, Marilda de Souza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829363/ https://www.ncbi.nlm.nih.gov/pubmed/29619129 http://dx.doi.org/10.1155/2018/6105691

Ejemplares similares

Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia
por: Yahouédéhou, Sètondji Cocou Modeste Alexandre, et al.
Publicado: (2019)

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response
por: Yahouédéhou, Sètondji Cocou Modeste Alexandre, et al.
Publicado: (2020)

TGFBR3 Polymorphisms (rs1805110 and rs7526590) Are Associated with Laboratory Biomarkers and Clinical Manifestations in Sickle Cell Anemia
por: Santiago, Rayra Pereira, et al.
Publicado: (2020)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
por: dos Santos Neres, Joelma Santana, et al.
Publicado: (2023)

Leg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile
por: Santos, Edvan do Carmo, et al.
Publicado: (2023)

A Description of the Hemolytic Component in Sickle Leg Ulcer: The Role of Circulating miR-199a-5p, miR-144, and miR-126
por: Santos, Edvan do Carmo, et al.
Publicado: (2022)

Genetic Polymorphisms Associated with Environmental Exposure to Polycyclic Derivatives in African Children
por: de Oliveira, Rodrigo Mota, et al.
Publicado: (2018)

Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease
por: Menezes, Joelma Figueiredo, et al.
Publicado: (2023)

Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers
por: Figueiredo, Camylla Vilas Boas, et al.
Publicado: (2021)

Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients
por: Guarda, Caroline C., et al.
Publicado: (2019)

Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC)
por: da Guarda, Caroline Conceição, et al.
Publicado: (2020)

Effect of N(Epsilon)-(carboxymethyl)lysine on Laboratory Parameters and Its Association with β(S) Haplotype in Children with Sickle Cell Anemia
por: Ndidi, Uche Samuel, et al.
Publicado: (2019)

Investigation of Lipid Profile and Clinical Manifestations in SCA Children
por: da Guarda, Caroline Conceição, et al.
Publicado: (2020)

Evaluation of Cardiometabolic Parameters among Obese Women Using Oral Contraceptives
por: Ferreira, Júnia Raquel Dutra, et al.
Publicado: (2017)

Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia
por: Aleluia, Milena Magalhães, et al.
Publicado: (2017)

Transforming Growth Factor Beta Receptor 3 Haplotypes in Sickle Cell Disease Are Associated with Lipid Profile and Clinical Manifestations
por: Santiago, Rayra P., et al.
Publicado: (2020)

Association of laboratory markers and cerebral blood flow among sickle cell anemia children
por: Adanho, Corynne Stéphanie Ahouéfa, et al.
Publicado: (2022)

Associations between TGF-β1 Levels and Markers of Hemolysis, Inflammation, and Tissue Remodeling in Pediatric Sickle Cell Patients
por: Santiago, Rayra P., et al.
Publicado: (2021)

Hydroxyurea Scavenges Free Radicals and Induces the Expression of Antioxidant Genes in Human Cell Cultures Treated With Hemin
por: Santana, Sânzio Silva, et al.
Publicado: (2020)

Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review
por: Miranda, Gustavo Marinho, et al.
Publicado: (2021)

Nasopharyngeal and Oropharyngeal Colonization by Staphylococcus aureus and Streptococcus pneumoniae and Prognostic Markers in Children with Sickle Cell Disease from the Northeast of Brazil
por: Rocha, Larissa C., et al.
Publicado: (2017)

Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease
por: Carvalho, Magda Oliveira Seixas, et al.
Publicado: (2017)

Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles
por: Aleluia, Milena Magalhães, et al.
Publicado: (2017)

Evaluation of 2D and 3D Erythroid Differentiation Protocols Using Sickle Cell Disease and Healthy Donor Induced Pluripotent Stem Cells
por: Martins, Gabriele Louise Soares, et al.
Publicado: (2023)

Laboratory and Genetic Biomarkers Associated with Cerebral Blood Flow Velocity in Hemoglobin SC Disease
por: Santiago, Rayra Pereira, et al.
Publicado: (2017)

Endothelial Nitric Oxide Synthase (−786T>C) and Endothelin-1 (5665G>T) Gene Polymorphisms as Vascular Dysfunction Risk Factors in Sickle Cell Anemia
por: Vilas-Boas, Wendell, et al.
Publicado: (2016)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Vaso‐occlusive crisis in a patient with sickle cell trait and COVID‐19
por: Freitas, Luiz A. R., et al.
Publicado: (2021)

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease
por: de Araujo, Olinda Maria Rodrigues, et al.
Publicado: (2015)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

Association of the clinical profile and overall survival of pediatric patients with acute lymphoblastic leukemia
por: Correa, Bruno Terra, et al.
Publicado: (2023)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Emerging Science of Hydroxyurea Therapy for Pediatric Sickle Cell Disease
por: Green, Nancy S., et al.
Publicado: (2013)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
por: Wong, Trisha E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_56bvn23d5uimertq719oc3bm7o